Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.
Fusarium infections in solid organ transplant recipients are often localized, occur later in the post-transplantation period, and have a better outcome than fusarial infections in patients with hematologic malignancies or bone marrow transplants. We report the first case of proven peritonitis caused by Fusarium species in a renal transplant recipient which is also the first successfully managed with voriconazole. We also review previously reported cases of fusarial infection in solid organ transplant recipients.
Garbino
Jorge
J
Division of Infectious Diseases, Department of Internal Medicine, University of Geneva Hospitals, Geneva, Switzerland. jorge.garbino@hcuge.ch
Uckay
Ilker
I
Rohner
Peter
P
Lew
Daniel
D
Van Delden
Christian
C
D000935:Antifungal Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy; D003928:Diabetic Nephropathies / Q000628:therapy; D005260:Female; D005670:Fusarium; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology*; D016377:Organ Transplantation / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology*; D011743:Pyrimidines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole